Janus Henderson Group PLC Sells 273,276 Shares of STERIS plc (NYSE:STE)

Janus Henderson Group PLC trimmed its position in STERIS plc (NYSE:STE - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,413,306 shares of the medical equipment provider's stock after selling 273,276 shares during the quarter. Janus Henderson Group PLC owned about 1.43% of STERIS worth $290,517,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in STERIS during the 4th quarter worth approximately $30,000. Human Investing LLC purchased a new stake in shares of STERIS in the 4th quarter valued at approximately $31,000. Anfield Capital Management LLC increased its position in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the last quarter. Manchester Capital Management LLC increased its position in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Brown Brothers Harriman & Co. grew its position in shares of STERIS by 66.7% in the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider's stock valued at $45,000 after buying an additional 88 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Up 2.1%

STE traded up $5.24 during trading on Friday, hitting $252.12. The company had a trading volume of 1,623,045 shares, compared to its average volume of 543,886. The company has a market cap of $24.77 billion, a PE ratio of 53.53 and a beta of 0.96. The business has a 50-day moving average of $224.13 and a 200-day moving average of $219.31. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 1-year low of $200.98 and a 1-year high of $252.20.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, beating the consensus estimate of $2.59 by $0.15. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.47 billion. STERIS had a net margin of 8.66% and a return on equity of 13.91%. The firm's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.58 earnings per share. As a group, analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be paid a $0.57 dividend. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a yield of 0.90%. STERIS's payout ratio is presently 36.77%.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of recent research reports. Stephens reiterated an "overweight" rating and set a $250.00 price target on shares of STERIS in a research note on Thursday. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, JMP Securities raised their target price on shares of STERIS from $265.00 to $280.00 and gave the company a "market outperform" rating in a report on Friday. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $265.00.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.